Comparar compuestos

Seleccione hasta 3 compuestos para comparar protocolos, mecanismos, criterios de valoración y hallazgos de seguridad en paralelo.

SLU-PP-332

Mismo objetivo

Incluir al imprimir

Solo afecta la página impresa o el PDF. El aviso de uso exclusivo en investigación siempre se imprime.

Protocolo01

SLU-PP-332

Metabolismo / Peso

Viales · 5 / 10 mg

01Protocol

Viales: 5 / 10 mg
Datos de dosis: Referencia de laboratorio; no indicado

02Quick calculator

03Mechanism of action

SLU-PP-332 is a synthetic small-molecule (not peptide) agonist of the estrogen-related receptors (ERRα/β/γ), which regulate mitochondrial and fatty-acid metabolism. It is described as an exercise mimetic.

04Study endpoints

In mice it increased energy expenditure and fatty-acid oxidation, reduced fat-mass gain and improved insulin sensitivity in metabolic-syndrome models.
In mouse pressure-overload heart failure, it improved ejection fraction, reduced fibrosis and increased survival.

05Safety & regulatory findings

Not approved by the FDA or EMA for any indication; research-grade material is not a medicine.
Evidence is from mouse studies; no human trials are cited.

06Citations

2 referencias · ver